Formoterol/bromur de glicopirroni/budesonida per al tractament de manteniment de la malaltia pulmonar obstructiva crònica
Abstract
Formoterol / glycopyrronium bromide / budesonide (FOR / GLIC / BUD) is a fixed-dose combination (CDF) of a long-acting beta-2-adrenergic agonist (LABA), a long-acting muscarinic antagonist (LAMA). and an inhaled corticosteroid (CI) at a medium dose. It is indicated for the maintenance treatment of adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately controlled on the combination of an IC and a LABA or a combination of an LABA and a LAMA. The dosage is two inhalations twice a day using a pressurized cartridge inhaler (pMDI)
Keywords
Chronic obstructive pulmonary disease; COPD; Triple therapy; Budesonide; Glycopyrronium bromide; Formoterol
Bibliographic citation
Programa d'Harmonització Farmacoterapèutica. Formoterol/bromur de glicopirroni/budesonida per al tractament de manteniment de la malaltia pulmonar obstructiva crònica. Barcelona: Servei Català de la Salut; 2022.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/7124This item appears in following collections
The following license files are associated with this item: